With pharmaceutical supply chains under immense pressure due to the novel coronavirus, China’s role as a global ingredient producer has come under scrutiny. Despite fears the East Asian nation could shut off the tap for U.S. drugs, the FDA said it hasn’t yet noticed major signs for concern.
The FDA hasn’t seen a shortage of active pharmaceutical ingredients (API) sourced from China due to the ongoing novel coronavirus outbreak but is “closely monitoring the situation,” FDA Commissioner Stephen Hahn told Fox News on Sunday.
“We don’t have any evidence that there’s a drug in short supply because of anyone blocking the active pharmaceutical ingredients coming to us (from China),” Hahn said.
Watch the Free Webinar
Chemistry Through Biology: Translating Molecular Biology Technologies into Practical Processes for API Production
Learn about the key advances and critical hurdles in transforming emerging molecular biology technologies into practical applications with commercially viable processes.
China’s role as a major supplier of global API for generic and branded drugs has come into focus as the novel coronavirus and COVID-19 have increasingly strained the pharmaceutical supply chain in recent weeks.
Hahn highlighted reported spot shortages of certain drugs due to increased demand but said China’s API tap is still running, despite escalating rhetoric between the Chinese and U.S. governments. Hahn highlighted the Trump administration’s push to develop “advanced” manufacturing stateside to help drive greater redundancy in the supply chain.
twisted family secrets full movie limpiando culo snigdha sinha video anyxvideos.com sex slave full video view here ksb besaba com katrina reyal sex garden on house wife rape 1st sex young xnxx-br.com bd bdsexvideo sasur bhou sex romance bluepornsex video xxx vide0 gan czech teen swallow money گایدن افقانی anushka sharma ki video vdeo xxx japaeb fetishwife clare